Publications by authors named "Daniela Femia"

Claim this Profile
P
Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations.
Francesco Panzuto, Sara Pusceddu, Antongiulio Faggiano, Maria Rinzivillo, Nicole Brighi, Daniela Femia

Pancreatology· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm.
Federica Cavalcoli, Sara Pusceddu, Alessandra Zilli, Gianluca Tamagno, Daniela Femia

Scand J Gastroenterol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches.
Daniela Femia, Natalie Prinzi, Andrea Anichini, Roberta Mortarini, Federico Nichetti

Target Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.
Sara Pusceddu, Claudio Vernieri, Massimo Di Maio, Riccardo Marconcini, Francesca Spada, Daniela Femia

Gastroenterology· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors.
Sara Pusceddu, Francesco Barretta, Annalisa Trama, Laura Botta, Massimo Milione, Daniela Femia

Endocr Relat Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study.
Maria Rinzivillo, Nicola Fazio, Sara Pusceddu, Andrea Spallanzani, Toni Ibrahim, Daniela Femia

Pancreatology· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors.
Sara Pusceddu, Natalie Prinzi, Giuseppe Lo Russo, Daniela Femia, Massimo Milione

Future Oncol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Everolimus treatment for neuroendocrine tumors: latest results and clinical potential.
Sara Pusceddu, Elena Verzoni, Natialie Prinzi, Alessia Mennitto, Daniela Femia

Ther Adv Med Oncol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on medical treatment of small intestinal neuroendocrine tumors.
Sara Pusceddu, Daniela Femia, Giuseppe Lo Russo, Silvia Ortolani, Massimo Milione

Expert Rev Anticancer Ther· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Cerebellar Neuroendocrine Tumors: Chimeras or Real Entities? A Case Report with a 6-Year Follow-Up.
Claudio Vernieri, Daniela Femia, Sara Pusceddu, Carlo Capella, Juan Rosai

Case Rep Oncol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studies.
Sara Pusceddu, Filippo De Braud, Giuseppe Lo Russo, Laura Concas, Daniela Femia

Oncotarget· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes.
Sara Pusceddu, Roberto Buzzoni, Claudio Vernieri, Laura Concas, Sara Marceglia, Daniela Femia

Future Oncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis